Modulating the Antifungal Activity of Antimycotic Drugs with Farnesol
Introduction. Clinical strains of microorganisms, including opportunistic yeast-like fungi (YLF) of the genus Candida, are resistant to currently used antifungal drugs. In this regard, the search for alternative ways to potentiate the activity of antimicrobial agents in relation to the infectious ag...
Saved in:
| Main Authors: | N. P. Sachivkina, A. N. Senyagin, I. V. Podoprigora, D. G. Brown, V. V. Vissarionova |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
LLC Center of Pharmaceutical Analytics (LLC «CPHA»)
2021-11-01
|
| Series: | Разработка и регистрация лекарственных средств |
| Subjects: | |
| Online Access: | https://www.pharmjournal.ru/jour/article/view/937 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The effect of farnesol on the cAMP-PKA signaling pathway of Candida albicans biofilms and its correlation with drug resistance
by: WANG Yang, CHEN Xueyi, YU Shenjun, CAO Xuejiao, WEI Xin, YANG Xuan
Published: (2025-05-01) -
Micronutrient availability alters Candida albicans growth and farnesol accumulation: implications for studies using RPMI-1640
by: Cory H. T. Boone, et al.
Published: (2024-11-01) -
Synthesis, characterization and antifungal activity of coated silver nanoparticles-nystatin and coated silver nanoparticles-clotrimazol
by: Anwar Adil Hameed, et al.
Published: (2023-01-01) -
Recommendations on Selection of Antifungal Agents for the Treatment of Superficial Mycoses in People Living with Diabetes Mellitus
by: Amina Muhammad Idris, et al.
Published: (2024-07-01) -
Identification and determination of resistance to antimycotic factors in yeast clinical isolates during respiratory diseases
by: Irina S. Andreeva, et al.
Published: (2024-12-01)